Xtant Medical Receives FDA Clearance for Expanded Indications of Irix-A

Xtant Medical received FDA 510(k) clearance to market line extensions for the Irix-A standalone interbody spacer, including three new sizes and use with allograft. The new implants will launch within 2017.

The Irix-A Lumbar Integrated Fusion system comprises a titanium ring surrounded by an outer PEEK composite ring and three screws, plus an...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us